Inozyme Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $75,645,000.
Profit Margin
| 2018 | 0 | -6.96M | |
|---|---|---|---|
| 2019 | 0 | -18.61M | |
| 2020 | 0 | -55.83M | |
| 2021 | 0 | -56.41M | |
| 2022 | 0 | -65.44M | |
| 2023 | 0 | -71.16M |
INZY Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.29M | 1.17M | 1.05M | 217K | 83K | 0 |
Gross profit | -1.29M | -1.17M | -1.05M | -217K | -83K | 0 |
Operating exp. | ||||||
Research and development | 54.84M | 47.84M | 37.72M | 46.49M | 16.22M | 8.09M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 75.64M | 68.67M | 56.64M | 57.04M | 20.80M | 11.59M |
Operating income | -75.64M | -68.67M | -56.64M | -57.04M | -20.80M | -11.59M |
Other income (expenses), net | 4.47M | 1.61M | 22K | 617K | 1.08M | 4.34M |
Income before tax | -71.16M | -67.06M | -56.62M | -56.42M | -19.72M | -6.96M |
Income tax expense | 0 | -1.61M | -211K | -587K | -1.10M | 4.62M |
Net income | -71.16M | -65.44M | -56.41M | -55.83M | -18.61M | -6.96M |
Earnings per share | ||||||
Basic EPS | -1.37 | -1.73 | -2.39 | -2.39 | -1.23 | -0.46 |
Diluted EPS | -1.37 | -1.73 | -2.39 | -2.39 | -1.23 | -0.46 |
| Data source | Data source | Data source | Data source |